CRP and COVID-19: In a wider literature review conducted by Tjendra et al. (12) of multiple biomarkers incriminated in predicting COVID-19 severity, elevated inflammatory markers including elevated CRP was associated with a higher risk of disease progression to critical illness, a severe disease course, a higher risk of developing sepsis with rapid progression, and ultimately a higher risk of intubation and in-hospital mortality.